They've crunched the numbers, they've talked to the key industry opinion leaders and I am sure have been communicating with the company extensively. MST (and E&P Financial), as a result of this extensive research, have clearly also come to the conclusion that iTrack Advance is indeed "best in class" and will continue to see this company grow into a behemoth in the ophthalmology space, with strong sales and profit growth for many years to come. It's certainly not surprising that we have seen so many highly experienced and talented individuals such as Joy leaving much larger companies to join Nova Eye Medical, they want to be part of this journey.
Looking forward to seeing how things continue to progress here. The November sales update will be fantastic I'm sure, hopefully sufficient to leave no doubt in the mind of the market that the strong sales will indeed be sustained, and that high profitability is right on the horizon
On Track to Profitability, Price Target Increased (MST), page-3
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $33.21M | |||
| Open | High | Low | Value | Volume |
| 14.8¢ | 15.0¢ | 14.5¢ | $34.06K | 232.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 329492 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 244742 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |